Results 261 to 270 of about 30,099 (284)

Cabotegravir. HIV integrase inhibitor, anti-HIV agent

Drugs of the Future, 2015
null Han, Y., null Mesplede, T., null Wainberg, M.A.   +2 more
openaire   +1 more source

Resistance to HIV-1 integrase inhibitors: A structural perspective

Drug Resistance Updates, 2010
Jean-François Mouscadet, Anne Geneviève Marcelin, Luba Tchertanov   +2 more
exaly  

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Lancet, The, 2013
Andrey Shuldyakov, Carlos Brites, Jaime F Andrade-Villanueva   +2 more
exaly  

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Lancet, The, 2007
Jose M Gatell, Adriano Lazzarin
exaly  

HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis

Cell, 2016
Sebla B Kutluay, Alison Slaughter, James R Fuchs   +2 more
exaly  

HIV-1 integrase inhibitors

The Biomedical & Life Sciences Collection, 2011
openaire   +1 more source

The structural biology of HIV-1: mechanistic and therapeutic insights

Nature Reviews Microbiology, 2012
Alan N Engelman, Peter P Cherepanov
exaly  

HIV integrase inhibitors: a new era in the treatment of HIV

Expert Opinion on Pharmacotherapy, 2015
Gary G Whitlock, Ana Milinkovic
exaly  

HIV‐1 integrase inhibitors: 2005–2006 update

Medicinal Research Reviews, 2008
Raveendra Dayam, Rambabu Gundla, Nouri Neamati   +2 more
exaly  

HIV-1 integrase inhibitors: 2007-2008 update

Medicinal Research Reviews, 2010
Nouri Neamati
exaly